Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.42% 0.04% 8.759B 136653.1
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
0.23% 9.00% 1.524B Upgrade

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index composed of U.S. equities in the medical devices sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index includes medical equipment companies, including manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name iShares
Prospectus Benchmark Index
DJ US Select Medical Equip TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Greg Savage 13.26 yrs
Jennifer Hsui 8.59 yrs
Alan Mason 4.96 yrs
Amy Whitelaw 2.67 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 3
1.524B
-4.178B Category Low
8.066B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of March 31, 2021

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of April 16, 2021. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Name
2014
2015
2016
2017
2018
2019
2020
YTD
22.72%
9.69%
9.30%
30.81%
15.46%
32.75%
24.17%
7.73%
4.94%
-0.87%
7.51%
22.40%
-8.71%
27.67%
15.90%
10.27%
47.55%
10.90%
-19.59%
37.07%
-0.30%
19.74%
12.96%
-3.31%
25.42%
0.27%
-5.21%
21.82%
-1.33%
22.26%
28.00%
6.49%
27.19%
5.26%
1.01%
25.45%
9.58%
22.35%
17.67%
11.42%
17.29%
5.98%
-6.03%
20.44%
2.83%
23.22%
12.75%
4.67%
As of April 16, 2021.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (4-19-21) 0.23%
30-Day SEC Yield (3-31-20) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 40.47
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of April 14, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of April 14, 2021

Asset Allocation

As of April 14, 2021.
Type % Net % Long % Short
Cash 0.19% Upgrade Upgrade
Stock 99.81% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Abbott Laboratories 13.87% 124.67 0.26%
Thermo Fisher Scientific Inc 12.13% 487.68 -1.06%
Medtronic PLC 10.76% 126.16 0.20%
Danaher Corp 8.15% 242.02 -0.43%
Intuitive Surgical Inc 4.59% 810.46 -0.26%
Stryker Corp 4.42% 256.84 -0.11%
Becton, Dickinson and Co 4.41% 259.05 -0.72%
Boston Scientific Corp 4.01% 40.22 -1.69%
Edwards Lifesciences Corp 3.84% 88.46 -0.63%
IDEXX Laboratories Inc 3.13% 528.18 -1.27%

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index composed of U.S. equities in the medical devices sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index includes medical equipment companies, including manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name iShares
Prospectus Benchmark Index
DJ US Select Medical Equip TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Greg Savage 13.26 yrs
Jennifer Hsui 8.59 yrs
Alan Mason 4.96 yrs
Amy Whitelaw 2.67 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (4-19-21) 0.23%
30-Day SEC Yield (3-31-20) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 40.47
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of April 14, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of April 14, 2021

Fund Details

Key Dates
Inception Date 5/1/2006
Last Annual Report Date 3/31/2020
Last Prospectus Date 8/17/2020
Attributes
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No